Veru (VERU) Intangibles (2016 - 2023)
Veru (VERU) posted quarterly Intangibles of $5952.0 for Q3 2023, down 99.85% year-over-year from $4.0 million in Q3 2022, and down 98.81% quarter-over-quarter from $500000.0 in Q2 2023.
Veru (VERU) Intangibles (2016 - 2023) Analysis & Trends
Veru (VERU) has reported Intangibles for 8 consecutive years, with $5952.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Intangibles fell 99.85% year-over-year to $5952.0; the TTM figure through Sep 2023 stood at $5952.0 (down 99.85% YoY), while the FY2023 annual figure was $5952.0, down 99.85% from the prior year.
- Intangibles slipped to $5952.0 in Q3 2023 per VERU's latest filing, from $500000.0 in the prior quarter.
- Across five years, Intangibles topped out at $20.9 million in Q3 2019 and bottomed at $5952.0 in Q3 2023.
- Historically, Intangibles has averaged $4.2 million across 5 years, with a median of $4.0 million in 2022.
- Annual changes were most pronounced in 2019 — Intangibles jumped 620.69% — and 2023, when it slumped 99.85%.
- Veru's Intangibles stood at $2.9 million in 2019, then soared by 41.46% to $4.1 million in 2020, then grew by 7.25% to $4.4 million in 2021, then retreated by 10.01% to $4.0 million in 2022, then plunged by 99.85% to $5952.0 in 2023.
- Business Quant data shows VERU's Intangibles at $5952.0 in Q3 2023, $500000.0 in Q2 2023, and $500000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 5,952.00 |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 3.96 Mn |
| Sep 30, 2022 | 3.98 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 4.40 Mn |
| Dec 31, 2021 | 4.40 Mn |
| Sep 30, 2021 | 4.05 Mn |
| Jun 30, 2021 | 4.07 Mn |
| Mar 31, 2021 | 4.08 Mn |
| Dec 31, 2020 | 4.10 Mn |
| Sep 30, 2020 | 5.75 Mn |
| Jun 30, 2020 | 2.90 Mn |
| Mar 31, 2020 | 2.90 Mn |
| Dec 31, 2019 | 2.90 Mn |
| Sep 30, 2019 | 20.90 Mn |
| Jun 30, 2019 | 2.90 Mn |
| Mar 31, 2019 | 2.90 Mn |
| Dec 31, 2018 | 20.40 Mn |